These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 16022188

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Affinity-based screening techniques for enhancing lead discovery.
    Comess KM, Schurdak ME.
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):411-6. PubMed ID: 15338950
    [Abstract] [Full Text] [Related]

  • 23. Drug-DNA recognition: energetics and implications for design.
    Haq I, Ladbury J.
    J Mol Recognit; 2000 Jul; 13(4):188-97. PubMed ID: 10931556
    [Abstract] [Full Text] [Related]

  • 24. NMR fragment screening: tackling protein-protein interaction targets.
    Schade M, Oschkinat H.
    Curr Opin Drug Discov Devel; 2005 May; 8(3):365-73. PubMed ID: 15892252
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Fragment-based activity space: smaller is better.
    Hesterkamp T, Whittaker M.
    Curr Opin Chem Biol; 2008 Jun; 12(3):260-8. PubMed ID: 18316043
    [Abstract] [Full Text] [Related]

  • 27. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
    Moore JM.
    Biopolymers; 1999 Jun; 51(3):221-43. PubMed ID: 10516573
    [Abstract] [Full Text] [Related]

  • 28. Applications of high-throughput ADME in drug discovery.
    Kassel DB.
    Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
    [Abstract] [Full Text] [Related]

  • 29. Structure-guided fragment screening for lead discovery.
    Verdonk ML, Hartshorn MJ.
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949
    [Abstract] [Full Text] [Related]

  • 30. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR.
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [Abstract] [Full Text] [Related]

  • 31. Biophysics in drug discovery: impact, challenges and opportunities.
    Renaud JP, Chung CW, Danielson UH, Egner U, Hennig M, Hubbard RE, Nar H.
    Nat Rev Drug Discov; 2016 Oct; 15(10):679-98. PubMed ID: 27516170
    [Abstract] [Full Text] [Related]

  • 32. Fragment-based lead discovery: leads by design.
    Carr RA, Congreve M, Murray CW, Rees DC.
    Drug Discov Today; 2005 Jul 15; 10(14):987-92. PubMed ID: 16023057
    [Abstract] [Full Text] [Related]

  • 33. Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.
    Vogt A, Lazo JS.
    Pharmacol Ther; 2005 Aug 15; 107(2):212-21. PubMed ID: 15925410
    [Abstract] [Full Text] [Related]

  • 34. High-throughput protein crystallography and drug discovery.
    Tickle I, Sharff A, Vinkovic M, Yon J, Jhoti H.
    Chem Soc Rev; 2004 Oct 20; 33(8):558-65. PubMed ID: 15480479
    [Abstract] [Full Text] [Related]

  • 35. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD.
    J BUON; 2007 Sep 20; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [Abstract] [Full Text] [Related]

  • 36. Virtual compound screening in drug discovery.
    Stumpfe D, Ripphausen P, Bajorath J.
    Future Med Chem; 2012 Apr 20; 4(5):593-602. PubMed ID: 22458679
    [Abstract] [Full Text] [Related]

  • 37. NMR fragment screening: Advantages and applications.
    Schade M.
    IDrugs; 2006 Feb 20; 9(2):110-3. PubMed ID: 16523400
    [Abstract] [Full Text] [Related]

  • 38. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA.
    Future Med Chem; 2010 Nov 20; 2(11):1703-16. PubMed ID: 21428840
    [Abstract] [Full Text] [Related]

  • 39. Natural products in drug discovery.
    Harvey AL.
    Drug Discov Today; 2008 Oct 20; 13(19-20):894-901. PubMed ID: 18691670
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.